The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson’s disease

Abstract

It is now well accepted that theory of mind (ToM) functioning is impaired in Parkinson’s disease (PD) patients. However, what remain unknown are the functions that underlie this impairment. It has been suggested that cognitive skills may be key in this area of functioning; however, many of the cognitive tests used to assess this have relied on intact visuospatial abilities. This study aimed to examine whether deficits in ToM were generated by cognitive or visuospatial dysfunction and the mediating effect of visuospatial function on ToM performance. Fifty PD patients (31 male, 19 female; mean age = 66.34 years) and 49 healthy controls (16 male, 33 female; mean age = 67.29 years) completed a ToM task (reading the mind in the eyes) and visuospatial task (line orientation). The results revealed that current cognitive status was a significant predictor for performance on the ToM task, and that 54% of the total effect of cognitive status on ToM was mediated by visuospatial abilities. It was concluded that visuospatial functioning plays an important mediating role for the relationship between executive dysfunction and affective ToM deficits in PD patients, and that visuospatial deficits may directly contribute to the presence of affective ToM difficulties seen in individuals with PD.

Introduction

Parkinson’s disease (PD) is a neurodegenerative disorder marked by motor symptoms including rigidity, bradykinesia, postural problems, and resting tremor.¹ Nonmotor symptoms are also a frequent feature, including executive dysfunction, cognitive decline, and visuospatial deficits, which can be equally disabling for individuals with PD.^1,2 Deficits in theory of mind (ToM), the ability to attribute mental states to one’s self and others, are also common. Indeed, the cognitive deficits exhibited in PD are said to resemble those produced after frontal lobe damage.³ Although not well understood, deficits in ToM are important, as difficulties in this area may reduce the individual’s sensitivity to social cues, leading to social isolation and impacting on quality of life.^4,5 However, it remains unclear whether ToM deficits in PD are due to cognitive decline associated with the disorder,⁶ or visuospatial deficits which also appear early in the disease process.¹

As mentioned above, a series of studies have highlighted that ToM is impaired in some patients with PD. For instance, participants with PD have been reported to perform more poorly on first-order and second-order belief ToM tasks compared to healthy controls.^4–6 Furthermore, similar studies have demonstrated worse performance by those with PD compared to individuals without PD on ToM tasks involving cartoons,⁷ attributing emotions,⁸ recognizing facial expressions,⁹ and the “reading the mind in the eyes” task.¹⁰ In an interesting study, irony comprehension and ToM processing were examined in individuals with PD.¹¹ Pragmatic stories involving either irony or lying were presented to participants with PD and healthy controls, and the results indicated that PD participants demonstrated deficits in the ability to distinguish between lying versus ironic intent. Further, the PD patients were also impaired when answering questions regarding second-order beliefs of the story characters.¹¹

While studies have highlighted an overall deficit of ToM in PD patients, others have attempted to differentiate the subcomponents of ToM. As such, research has identified two subcomponents: cognitive ToM, the ability to understand others’ intentions and beliefs, and affective ToM, the ability to identify the emotional states of others.¹² Further, studies have reported these subcomponents to be related to different brain regions, with cognitive ToM thought to be mediated by the dorsolateral frontostriatal circuitry, and affective ToM primarily by the orbital frontostriatal circuitry.⁸

Through the use of different ToM tasks, studies have compared performance of PD and non-PD participants in cognitive and affective ToM functioning, and while authors have reported only deficits in cognitive ToM,¹³ others have also indicated additional decreased performance on affective ToM functioning.^8,12 Bodden et al¹² specifically investigated affective and cognitive ToM functioning in PD, finding that participants with PD scored significantly lower on both the cognitive and affective ToM subscales but not on the control (memory and facts) items.

In light of the above findings, there is now a focus on identifying the potential correlates of ToM deficits in patients with PD, and it has been suggested that problems with ToM reflect the presence of cognitive deficits.⁶ In a study investigating decision-making in patients with PD, performance on tasks involving ToM, executive functioning, and decision-making revealed that while participants with PD exhibited worse performance than controls on all three outcomes, ToM and decision-making did not correlate with executive functioning.¹⁴ Considering the large reliance on visual-processing in the measures of ToM, such as recognition of emotional expressions, facial processing, and the reading the mind in the eyes task, it may be suggested that visuospatial functioning deficits mediate the relationship between ToM deficits and PD. The aim of this study was to explicitly examine whether deficits in ToM were generated by cognitive or visuospatial dysfunction and the mediating effect of visuospatial function on performance on a ToM task.

Methods

Participants and procedure

Ninety-nine participants were recruited from a database of PD patients (31 males, 19 females; mean [M] age = 66.34 years, standard deviation [SD] = 6.71 years) and healthy controls (16 males, 33 females; M age = 67.29 years, SD = 5.73 years) from the greater Canterbury region. A neurologist who specialized in movement disorders diagnosed the 50 PD patients. Inclusion criteria: (a) a diagnosis of idiopathic Parkinson’s disease, assessed at the Hoehn and Yahr¹⁵ stage 1–1V; (b) between 50 and 80 years of age; (c) adequate or corrected hearing and vision (self-report checked by examiner); (d) no signs of overt dementia, with mental status examine score of <25.¹⁶ Exclusion criteria comprised a history of: (a) moderate/severe traumatic brain injury; (b) stroke or other neurological impairments other than PD; (c) major medical illness; (d) alcohol or substance abuse; (e) currently taking medications known to have a significant effect on the central nervous system (other than medications prescribed for the control of PD symptoms). All PD patients were on optimal levels of anti-Parkinsonian medication during participation.

The study was approved by the local ethics committee, and all subjects gave written consent prior to participation. Testing was conducted at the University of Canterbury.

Measures

• Theory of mind task – reading the mind in the eyes task.¹⁷ Participants were presented with a partial picture of a face showing only the eye-region, and at each of the four corners of the picture was a word. They were then asked to make a judgment about which one of the words most closely matched what the person in the picture might be thinking or feeling. The task consists of 36 test items which were scored 0 for incorrect and 1 for correct choices.

• Visuospatial ability, assessed using the judgment of line orientation test.¹⁸ This test is frequently used to assess visuospatial function, whereby participants are presented with a booklet containing a series of card pairs. One of the card pairs, the response card was displayed at the bottom of the page and contained an array of eleven numbered lines (3.8 cm in length), and each was separated by an angle of 18 degrees. The participant was asked to identify the orientation of two lines on the bottom card by identifying the two lines with the same orientation from the eleven-line array. Each participant was presented with five practice items and 30 tests items. Responses for each line pair were scored 0 for an incorrect response and 1 for a correct response.

• Symptoms of depression, assessed with the Beck Depression Inventory, 2nd edition (BDI-II).¹⁹ The BDI-II is a brief, 21 item, self-report questionnaire that assesses an individual’s mood over the previous 2-week period. Each item was rated on a four-point scale from 0–3. Higher scores indicated the presence of a greater number of depressive symptoms.

• Cognitive status, assessed using the modified mini mental state exam.¹⁶ This test involves 30 questions and examines cognitive aspects of mental functioning such as orientation, memory, attention, and ability to follow complex commands. Scores higher than or equal to 25 indicate normal cognitive functioning.

See Table 1 for clinical information broken down by demographic characteristic for each group. Information has been provided separately for males and females.

Table 1.

Clinical profile of participants by demographics

	3MS M (SD)	H and Y M (SD)	BDI-II M (SD)
PD males	94.52 (5.00)	2.26 (0.82)	8.52 (6.42)
PD females	94.11 (4.48)	2.08 (0.84)	8.74 (7.13)
Control males	96.69 (3.84)	–	4.81 (4.31)
Control females	97.27 (3.18)	–	4.12 (3.20)

Abbreviations: 3MS, modified mini mental state examination; BDI-II, Beck Depression Inventory, 2nd edition; H and Y, Hoehn and Yahr stage; M, mean; SD, standard deviation; PD, Parkinson’s diease.

Results

Preliminary analyses

To determine if there were differences between PD patients and controls on key variables (age, depression, current cognitive status), a 2 × 2 (sex × disease interaction [PD versus control]) multivariate analysis of variance was conducted with age, BDI-II scores, and modified mini mental state scores as the dependent variables. As expected the results revealed a significant main effect for disease on current cognitive status with PD patients (M = 94.31) demonstrating a significantly lower level of cognitive functioning than healthy controls (M = 96.98) (F[1,95] = 9.21, P = 0.003, η_p² = 0.09). There was also a significant main effect for disease on symptoms of depression with PD patients (M = 8.63) endorsing greater levels of depression symptomatology than healthy controls (M = 4.47) (F[1,95] = 13.42, P = 0.001, η_p² = 0.13). Finally, the results revealed a significant sex × disease interaction for age, with male controls (M = 69.50 years) older than male PD patients (M = 65.39 years), whereas female controls (M = 66.21 years) were younger than female PD patients (M = 67.90 years) (F[1,95] = 5.00, P = 0.028, η_p² = 0.05). Post hoc analyses did not reveal significant differences between these means. Given the significant differences in levels of depression symptomatology for PD versus controls, the significant sex × disease interaction for age, and the unequal distribution of males and females across the groups, BDI-II scores and sex were entered as covariates for all the main analyses.

Effect of cognitive functioning on theory of mind

To test the prediction that current cognitive status is predictive of ToM, independent of PD presence, ToM was regressed on cognitive status and disease, while controlling for sex and depression symptomology. The results revealed as expected current cognitive status was a significant predictor of ToM (β = 0.31, t = 3.11, P = 0.003), with lower cognitive functioning indicative of ToM deficits. Further, disease was also an independent predictor of ToM (β = 0.233, t = 2.14, P = 0.035), with PD patients having significantly lower levels of ToM than controls.

Mediational analyses

To test the prediction that the effect of cognitive functioning on ToM is mediated by deficits in visuospatial skills for PD patients, a bootstrap serial mediational analysis was conducted following the procedures from Hayes.²⁰ ToM was entered as the dependent variable, disease as the independent variable, current cognitive status and visuospatial abilities as the mediator, and depression symptomology and sex as covariates. The results (shown in Figure 1), revealed the total effect of disease on ToM (b = 3.61, P = 0.003) became nonsignificant with the introduction of cognitive functioning and visuospatial abilities into the model (total direct effect: b = −1.28, P = 0.27).

Figure 1.

Current cognitive functioning and visuospatial abilities jointly mediate the effects of Parkinson’s disease on affective theory of mind, controlling for sex and depression symptomology.

Notes: All numbers are unstandardized coefficients. The path in parentheses indicates the direct association between disease and theory of mind. ^**P < 0.01; ^***P < 0.001.

The total indirect effect of disease on ToM through cognitive function and visuospatial abilities was significant, with a point estimate of −2.33, 95% confidence interval (CI) −3.86 to −0.99. The specific indirect effect of disease on ToM through both cognitive functioning and visuospatial abilities was significant (effect estimate: −0.77, 95% CI −1.67 to −0.20). The specific indirect effect of disease on visuospatial abilities through cognitive functioning was not significant (effect estimate: −0.30, 95% CI −1.67 to 0.69). The specific indirect effect of cognitive functioning on ToM through visuospatial abilities was significant (effect estimate: −1.25, 95% CI −2.54 to −0.24). These results indicate that although visuospatial ability mediates the effects of cognitive functioning on ToM, more importantly both cognitive functioning and visuospatial ability work in conjunction to mediate the effects of disease on ToM, with the path from disease to visuospatial ability not mediated by cognitive functioning. In sum, PD is associated with lower levels of cognitive functioning, which in turn effects visuospatial functioning, which in turn influences ToM. The direct effects of disease on ToM and cognitive functioning on ToM are all accounted for by visuospatial ability.

Discussion

The aim of this study was to examine whether ToM deficits detected in patients with PD were associated with cognitive status or visuospatial dysfunction, and to explore the mediating effect of visuospatial function on performance with a ToM task. We found that while current cognitive status was a significant predictor for performance on the ToM task, the association between PD and ToM and the total effect of cognitive status on ToM was being mediated by visuospatial abilities.

Our research is consistent with a number of other studies.^8–10,12 However, there is considerable controversy regarding the timing of different ToM deficits, with some arguing that deficits in cognitive ToM emerge prior to deficits in affective ToM,¹³ whereas others argue the opposite.⁸ The timing of these deficits may be connected with the type of skill captured within the task. For example, visuospatial abilities, which are typically utilized in affective ToM tasks, are also seen to decline early on in the disease process.¹ Specific ToM tasks used to assess functioning may contribute to the inconsistent findings in this area as different subcomponents of ToM are assessed by different tests. Some ToM tasks rely on cognitive processing alone (ie, tasks that involve vignettes and pragmatic stories), whereas others rely on visual processing (ie, facial recognition, emotion recognition). The extent to which these tasks draw upon cognitive processing will determine the strength of the relationship between ToM deficits and executive functioning/cognitive decline.

A number of studies have sought to examine the association between executive function and ToM. However, as mentioned above, many tests of executive function and ToM processing also involve visuospatial components. The visuospatial deficits seen in PD patients have been associated with lesions in the right posterior cortex.²¹ Since visuospatial functioning deficits are evident early in the process of PD, it is plausible that visuospatial dysfunction may explain ToM deficits.²² Our study only included participants with adequate or corrected vision, therefore any deficits exhibited on the ToM task would not be due to pure visual deficits. The role of visuospatial deficits in recognizing emotional expression relates to how the images of the eyes are perceived as a whole. The test in this study involves processing the visual information in the pictures in an integrated manner – a process which may be greatly affected by visuospatial deficits.

Many have refuted the role of cognitive decline in ToM processing in PD, with studies reporting deficits in ToM tasks (which relied heavily on visuospatial abilities) to be unrelated to executive functioning.^10,12,14 Our study demonstrates that visuospatial functioning mediates the relationship between cognitive decline and ToM and is consistent with research on normal aging, which indicates that declines in social cognition and ToM processing is at least partially independent of more general cognitive or executive decline.²³ It has been suggested that while it is not uncommon to see cognitive decline as a general consequence of normal aging, deficits in social cognition and ToM do not often follow.^23,24 Considering that declines in ToM processing are not commonly associated with general cognitive decline in normal aging, it may be that these phenomena seen in PD patients are due to the additional deficits of visuospatial functioning. Furthermore, even when social cognitive processing has been reported in normal aging, it is not always related to general executive dysfunction.²³

A point to consider regarding our findings is whether ToM deficits seen in PD are actually a display of the combined effects of visuospatial and cognitive deficits, both common in PD, and not ToM deficits at all. Indeed this is plausible considering ToM tests will either assess some form of cognitive processing or visuospatial processing, or both (as discussed above). However, this study found that cognitive functioning was not a significant predictor of ToM deficits when visuospatial abilities were considered in the analyses, which therefore suggests ToM is not purely a cognitive deficit. In effect, this implies that there are more to these deficits seen in PD patients than what would be seen from deficits in visuospatial functioning and cognition alone.

It is important to note the methodological weaknesses of our study. For example, the patients were only assessed during the medicated state, but research has shown that the medications can have a positive effect on cognitive function. Further, only one assessment of visuospatial functioning was utilized, which may restrict the ability to generalize results. The use of more than one visuospatial test may have provided more robust findings for the role of visuospatial processing in ToM. Similarly, in this study, only affective ToM was assessed. The test involved inferring one’s emotions from a picture, which typically derives an index of affective as opposed to cognitive ToM processing. As a consequence, only affective ToM was assessed. Using a cognitive ToM task as well as the affective task would have enabled us to examine whether visuospatial deficits contribute to ToM difficulties as a whole. Further, the significant difference in sex ratio and depression symptomatology between the two participant groups was also of concern; however, these variables were controlled for as covariates and therefore not deemed to present any impact on the results of the study.

Future work in this area therefore should seek to replicate the results found in our study, as to date, no study has investigated the mediating role of visuospatial functioning in ToM in PD patients. More specifically, studies should include the use of other/multiple visuospatial assessment, beyond the line orientation task, to ensure these findings can be generalized. In addition, future studies should assess the mediating role of visuospatial functioning on both affective and cognitive ToM, and ToM as a whole in PD patients, through the use of multiple ToM tasks which utilize visual processing skills.

It may be concluded that visuospatial functioning plays an important mediating role for the relationship between executive dysfunction and affective ToM deficits in PD patients. Moreover, these results suggest that visuospatial deficits may directly contribute to the presence of ToM difficulties seen in individuals with PD, even in the early stages.